Cardiovascular Diseases Fellow @MayoClinicCV @MayoCVFellows via @PittDeptofMed @ChariteBerlin

Joined July 2014
64 Photos and videos
Pinned Tweet
Week 1 of the fellowship is in the books. I’m extremely excited to be part of this incredible program and team of fellows. @MayoCVFellows @MayoClinic #CardioTwitter #MedTwitter
8
2
131
10,466
Mohanad Hamandi, MD retweeted
AR index: DBP-LVEDP/SBP^ 100: < 25 Low index= more severe AR Provides simple, practical way to calculate acute AR/perileak during TAVR
2
21
82
5,136
Mohanad Hamandi, MD retweeted
Grateful for the opportunity to speak at @MayoClinicCV Grand Rounds on #AI and #healthequity. Thank you for such a warm, welcoming visit and the chance to share and learn together. A special thank you to @SharonneHayes for hosting a wonderful dinner, and appreciation to the fellows and faculty including Paul Friedman, Rajiv Gulati, @drlopezjiminez @HamandiMd @mielniczuk_lisa @MDMankad @Dobeze_ @joyfuldockemi @MayraGuerreroMD @PanithayaC @stanhenkin @pattypellikka for such thoughtful conversations.
1
4
20
2,407
We had the pleasure of hosting Dr @ditchhaporia former president of the American College of Cardiology, for grand rounds, where she also offered candid career guidance for fellows @FadiAdelMD @MayoClinicCV @MayoCVFellows
1
1
20
3,103
Mohanad Hamandi, MD retweeted
My summary slide. Follow these simple principles in life and you will enjoy your career as an interventional cardiologist
7
61
192
11,296
Mohanad Hamandi, MD retweeted
Visualization of the left atrial appendage will never be the same! My #NaughtyFellow found a windsock, a chicken wing, broccoli, and cactus in the LAA space! Transillumination and transparency is the way to go. No need for CT! #EchoFirst Read more here: onlinejase.com/article/S0894…
15
63
190
Mohanad Hamandi, MD retweeted
6
10
37
5,081
Full-body vs cerebral-only protection in TAVI-does it matter? The PROTECT H2H trial puts Emboliner head-to-head with Sentinel. Tune in to listen directly from @AdamGreenbaumMD @FITsOnTheGo @MayoClinicCV @emory_heart PROTECT The H2H: Emboliner vs. Sentinel Embolic Protection Devices in TAVR youtu.be/HjFwxNYEWDI?si=PlO5… via @YouTube
1
6
759
Mohanad Hamandi, MD retweeted
Arab American Society of Cardiology second annual meeting 🫀🫀♥️
2
18
960
Learned that building a procedural niche requires disciplined focus, while maintaining openness to adapt and expand the direction of both clinical practice and research. Thanks Dr Cohen for your time and insights @djc795 @MayoClinicCV @crfheart
🎥 Clinical Investigator Career in Interventional Cardiology Dr. David J. Cohen shares insights on building a career at the intersection of research, innovation, and patient care ▶️ Full interview on YouTube: youtube.com/watch?v=uf0etWHV… #ACC #FITsOnTheGo @djc795 @HamandiMd
1
1
8
1,414
Mohanad Hamandi, MD retweeted
Leadership team FITs On the Go #ACC26
5
41
2,795
Mohanad Hamandi, MD retweeted
Best senior resident & mentor on the block! ➡️ Go see @HamandiMd !!! 🤗
Questions about @MayoClinicCV fellowship? Come chat with @HamandiMd TODAY @ Noon at #ACC26 booth #1201!
1
11
1,452
Mohanad Hamandi, MD retweeted
FITsOnTheGo is a @MayoClinicCV initiative led by fellows in training, featuring interviews with late-breaking trialists. Join us at the studio in the #ACC26 Learning Lounge, next to the Heart to Heart stage!
1
5
39
3,976
Mohanad Hamandi, MD retweeted
Today, the @MayoCVFellows were privileged to host @MKIttlesonMD as our annual Fellows' Visiting Professor. It was a day full of clinical gems, intense debate, and #kittlesonrules. Dr. Kittleson - thank you for joining us, and please come back soon to @MayoClinicCV @MayoClinic
2
6
49
16,125
Mohanad Hamandi, MD retweeted
I’m pleased to share that for the 8th consecutive year, Mayo Clinic is ranked the No. 1 hospital in the world by @Newsweek thanks to the extraordinary expertise, compassion, and commitment of our staff. rankings.newsweek.com/worlds…
5
47
140
9,059
Mohanad Hamandi, MD retweeted
Contratulations @HamandiMd for this important contribution! MAC with mitral valve dysfunction and tricuspid regurgitation often coexist. It's important to study this as we enter the commercial era for TMVR in MAC with already 1 TMVR device (Tendyne) FDA approved for patients with MAC in 2025. Keep up the good work @MayoClinicCV !
Presented our study on the prognostic impact of tricuspid regurgitation in patients with mitral annular calcification at TCT in San Francisco. Thanks Dr Guerrero and Dr Pellikka for your mentorship and support. @MayoClinicCV @MayoCVFellows @MayraGuerreroMD @pattypellikka
1
2
30
3,964
Mohanad Hamandi, MD retweeted
Grateful for an incredible experience at #TCT2025 — from presenting our latest research to connecting with mentors and catching up with friends. Huge thanks to @TCTMD @crfheart @MayoClinicCV @MayoCVFellows
3
7
68
18,994
Once the forgotten, tricuspid valve is now the center of attention. TR is the most prevalent valvular heart disease among U.S. adults aged 65 to 85 years. #TCT2025 #PREVUEVALVE
1
11
1,130
Presented our study on the prognostic impact of tricuspid regurgitation in patients with mitral annular calcification at TCT in San Francisco. Thanks Dr Guerrero and Dr Pellikka for your mentorship and support. @MayoClinicCV @MayoCVFellows @MayraGuerreroMD @pattypellikka
4
1
19
5,255
Here are the slides with more details. @MayraGuerreroMD
2
142